These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10551322)
41. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608 [TBL] [Abstract][Full Text] [Related]
43. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas. Collier SA; Madigan MC; Penfold PL Curr Eye Res; 2000 Aug; 21(2):662-8. PubMed ID: 11148603 [TBL] [Abstract][Full Text] [Related]
44. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Deryugina EI; Ratnikov B; Monosov E; Postnova TI; DiScipio R; Smith JW; Strongin AY Exp Cell Res; 2001 Feb; 263(2):209-23. PubMed ID: 11161720 [TBL] [Abstract][Full Text] [Related]
45. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073 [TBL] [Abstract][Full Text] [Related]
46. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249 [TBL] [Abstract][Full Text] [Related]
47. Expression of matrix metalloproteases (MMP-2, MT1 -MMP) and their tissue inhibitor (TIMP-2) by rat sertoli cells in culture: implications for spermatogenesis. Slongo ML; Zampieri M; Onisto M Biol Chem; 2002 Jan; 383(1):235-9. PubMed ID: 11928819 [TBL] [Abstract][Full Text] [Related]
48. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371 [TBL] [Abstract][Full Text] [Related]
49. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
50. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. Hara I; Miyake H; Hara S; Arakawa S; Kamidono S J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973 [TBL] [Abstract][Full Text] [Related]
51. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Zhang J; Hampton AL; Nie G; Salamonsen LA Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071 [TBL] [Abstract][Full Text] [Related]
52. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2. Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631 [TBL] [Abstract][Full Text] [Related]
53. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Jiang A; Lehti K; Wang X; Weiss SJ; Keski-Oja J; Pei D Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13693-8. PubMed ID: 11698655 [TBL] [Abstract][Full Text] [Related]
54. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. Kurschat P; Zigrino P; Nischt R; Breitkopf K; Steurer P; Klein CE; Krieg T; Mauch C J Biol Chem; 1999 Jul; 274(30):21056-62. PubMed ID: 10409657 [TBL] [Abstract][Full Text] [Related]
55. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis. Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994 [TBL] [Abstract][Full Text] [Related]
56. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296 [TBL] [Abstract][Full Text] [Related]
57. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998 [TBL] [Abstract][Full Text] [Related]
58. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Jo M; Thomas LE; Wheeler SE; Curry TE Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206 [TBL] [Abstract][Full Text] [Related]
59. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137 [TBL] [Abstract][Full Text] [Related]
60. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine. Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]